Serum anti-Mullerian hormone throughout the human menstrual cycle

被引:385
作者
La Marca, A.
Stabile, G.
Artenisio, A. Carducci
Volpe, A.
机构
[1] Univ Modena & Reggio Emilia, Mother Infant Dept, Inst Obstet & Gynecol, Policlin Modena, I-41100 Modena, Italy
[2] Univ Messina, Dept Med & Pharmacol, Messina, Italy
关键词
anti-Mullerian hormone; gonadotrophins; inhibin B; physiological menstrual cycle; sex steroids;
D O I
10.1093/humrep/del291
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The anti-Mullerian hormone (AMH) is a member of the transforming growth factor (TGF) superfamily. In women, AMH serum levels can be almost undetectable at birth, with a subtle increase noted after puberty. Data are lacking with regard to menstrual cycle day-to-day fluctuations. This longitudinal study was designed to investigate the pattern of secretion of AMH throughout the menstrual cycle in regularly cycling women. METHODS: Twelve healthy female subjects aged 18-24 years participated in this study. Blood samples were taken every other day throughout one menstrual cycle. Serum FSH, LH, estradiol (E-2), progesterone, inhibin B and AMH levels were assayed by double-antibody radioimmunoassay using commercial kits. RESULTS: Serum AMH in the first days of the menstrual cycle (days -14 to -12) was 3.8 +/- 1.2 ng/ml (mean +/- SD). No significant changes were observed in serum AMH levels throughout the menstrual cycle. The highest value was 3.9 +/- 1.3 ng/ml at day -12 and the lowest value was 3.4 +/- 1.1 ng/ml at day 14, and the difference was not significant. CONCLUSION: In this study, we demonstrated that serum AMH levels do not change significantly throughout the menstrual cycle. Hence, AMH exhibits a relatively stable expression during the menstrual cycle, making it an attractive determinant of ovarian activity.
引用
收藏
页码:3103 / 3107
页数:5
相关论文
共 26 条
[1]   ANTI-MULLERIAN HORMONE AND ANTI-MULLERIAN HORMONE TYPE-II RECEPTOR MESSENGER-RIBONUCLEIC-ACID EXPRESSION IN RAT OVARIES DURING POSTNATAL-DEVELOPMENT, THE ESTROUS-CYCLE, AND GONADOTROPIN-INDUCED FOLLICLE GROWTH [J].
BAARENDS, WM ;
UILENBROEK, JTJ ;
KRAMER, P ;
HOOGERBRUGGE, JW ;
VANLEEUWEN, ECM ;
THEMMEN, APN ;
GROOTEGOED, JA .
ENDOCRINOLOGY, 1995, 136 (11) :4951-4962
[2]   MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT [J].
BEHRINGER, RR ;
FINEGOLD, MJ ;
CATE, RL .
CELL, 1994, 79 (03) :415-425
[3]   Serum mullerian-inhibiting substance levels during normal menstrual cycles [J].
Cook, CL ;
Siow, Y ;
Taylor, S ;
Fallat, ME .
FERTILITY AND STERILITY, 2000, 73 (04) :859-861
[4]   Antimullerian hormone serum levels: a putative marker for ovarian aging [J].
de Vet, A ;
Laven, JSE ;
de Jong, FH ;
Themmen, APN ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2002, 77 (02) :357-362
[5]   Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary [J].
Durlinger, ALL ;
Kramer, P ;
Karels, B ;
de Jong, FH ;
Uilenbroek, JTJ ;
Grootegoed, JA ;
Themmen, APN .
ENDOCRINOLOGY, 1999, 140 (12) :5789-5796
[6]   Regulation of ovarian function: the role of anti-Mullerian hormone [J].
Durlinger, ALL ;
Visser, JA ;
Themmen, APN .
REPRODUCTION, 2002, 124 (05) :601-609
[7]   Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary [J].
Durlinger, ALL ;
Gruijters, MJG ;
Kramer, P ;
Karels, B ;
Kumar, TR ;
Matzuk, MM ;
Rose, UM ;
de Jong, FH ;
Uilenbroek, JTJ ;
Grootegoed, JA ;
Themmen, APN .
ENDOCRINOLOGY, 2001, 142 (11) :4891-4899
[8]   Anti-Mullerian hormone and its role in ovarian function [J].
Gruijters, MJG ;
Visser, JA ;
Durlinger, ALL ;
Themmen, APN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 211 (1-2) :85-90
[9]   AN IMMUNOASSAY TO DETECT HUMAN MULLERIAN INHIBITING SUBSTANCE IN MALES AND FEMALES DURING NORMAL DEVELOPMENT [J].
HUDSON, PL ;
DOUGAS, I ;
DONAHOE, PK ;
CATE, RL ;
EPSTEIN, J ;
PEPINSKY, RB ;
MACLAUGHLIN, DT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01) :16-22
[10]   Increased expression of Mullerian-inhibiting substance correlates with inhibition of follicular growth in the developing ovary of rats treated with E2 benzoate [J].
Ikeda, Y ;
Nagai, A ;
Ikeda, MA ;
Hayashi, S .
ENDOCRINOLOGY, 2002, 143 (01) :304-312